TYCC
LLY icon

Texas Yale Capital Corp’s Eli Lilly LLY Stock Holding History

Texas Yale Capital Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.28M Sell
5,744
-276
-5% -$280K 0.15% 97
2025
Q4 		$6.47M Buy
6,020
+60
+1% +$57.4K 0.2% 75
2025
Q3 		$4.55M Buy
5,960
+320
+6% +$238K 0.14% 104
2025
Q2 		$4.4M Buy
5,640
+178
+3% +$138K 0.14% 101
2025
Q1 		$4.51M Sell
5,462
-1,430
-21% -$1.19M 0.19% 93
2024
Q4 		$5.32M Buy
6,892
+172
+3% +$142K 0.21% 79
2024
Q3 		$5.95M Sell
6,720
-30
-0.4% -$27K 0.26% 62
2024
Q2 		$6.11M Buy
6,750
+118
+2% +$94.4K 0.29% 57
2024
Q1 		$5.16M Buy
6,632
+34
+0.5% +$24.2K 0.23% 74
2023
Q4 		$3.85M Buy
6,598
+1,108
+20% +$647K 0.18% 91
2023
Q3 		$2.95M Sell
5,490
-3,008
-35% -$1.55M 0.13% 105
2023
Q2 		$3.99M Sell
8,498
-111
-1% -$46.5K 0.19% 80
2023
Q1 		$2.96M Hold
8,609
– – 0.15% 112
2022
Q4 		$3.15M Buy
8,609
+7
+0.1% +$2.48K 0.18% 99
2022
Q3 		$2.78M Sell
8,602
-380
-4% -$120K 0.18% 105
2022
Q2 		$2.91M Buy
8,982
+76
+0.9% +$22.8K 0.19% 106
2022
Q1 		$2.55M Hold
8,906
– – 0.14% 137
2021
Q4 		$2.46M Buy
8,906
+161
+2% +$40.8K 0.13% 145
2021
Q3 		$2.02M Buy
8,745
+1
+0% +$247 0.11% 163
2021
Q2 		$2.01M Hold
8,744
– – 0.11% 162
2021
Q1 		$1.63M Sell
8,744
-49
-0.6% -$9.59K 0.1% 178
2020
Q4 		$1.49M Buy
8,793
+1
+0% +$149 0.1% 185
2020
Q3 		$1.3M Sell
8,792
-105
-1% -$16.3K 0.1% 180
2020
Q2 		$1.46M Sell
8,897
-2,624
-23% -$403K 0.12% 166
2020
Q1 		$1.6M Buy
11,521
+1
+0% +$137 0.16% 132
2019
Q4 		$1.51M Hold
11,520
– – 0.1% 187
2019
Q3 		$1.29M Hold
11,520
– – 0.09% 202
2019
Q2 		$1.28M Sell
11,520
-11,520
-50% -$1.36M 0.1% 203
2019
Q1 		$2.99M Buy
23,040
+11,520
+100% +$1.4M 0.12% 175
2018
Q4 		$1.33M Sell
11,520
-85
-0.7% -$9.49K 0.12% 168
2018
Q3 		$1.25M Hold
11,605
– – 0.1% 198
2018
Q2 		$990K Sell
11,605
-1,755
-13% -$144K 0.09% 217
2018
Q1 		$1.03M Sell
13,360
-105
-0.8% -$8.45K 0.09% 214
2017
Q4 		$1.14M Buy
13,465
+605
+5% +$51.5K 0.1% 202
2017
Q3 		$1.1M Sell
12,860
-1,755
-12% -$144K 0.1% 202
2017
Q2 		$1.2M Hold
14,615
– – 0.11% 177
2017
Q1 		$1.23M Buy
14,615
+3,000
+26% +$240K 0.11% 168
2016
Q4 		$854K Sell
11,615
-500
-4% -$37.2K 0.08% 228
2016
Q3 		$972K Hold
12,115
– – 0.09% 200
2016
Q2 		$954K Hold
12,115
– – 0.09% 199
2016
Q1 		$872K Sell
12,115
-275
-2% -$20.8K 0.09% 206
2015
Q4 		$1.04M Hold
12,390
– – 0.1% 177
2015
Q3 		$1.04M Buy
12,390
+160
+1% +$13.5K 0.1% 181
2015
Q2 		$1.02M Sell
12,230
-2,500
-17% -$190K 0.08% 200
2015
Q1 		$1.07M Sell
14,730
-3,900
-21% -$278K 0.09% 201
2014
Q4 		$1.28M Buy
18,630
+2,807
+18% +$189K 0.11% 144
2014
Q3 		$1.03M Buy
15,823
+1,003
+7% +$63.5K 0.1% 155
2014
Q2 		$921K Hold
14,820
– – 0.12% 160
2014
Q1 		$872K Buy
14,820
+775
+6% +$43.3K 0.12% 150
2013
Q4 		$716K Buy
14,045
+2,550
+22% +$128K 0.11% 146
2013
Q3 		$579K Hold
11,495
– – 0.1% 167
2013
Q2 		$565K Buy
+11,495
New +$625K 0.1% 165

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Texas Yale Capital Corp's LLY Position: Q1 2026 in Review

Texas Yale Capital Corp reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2026, selling an estimated $280K and leaving 5,744 shares worth $5.28M. The position accounts for 0.15% of the portfolio, ranked #97.

Texas Yale Capital Corp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.47M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Texas Yale Capital Corp held 5,744 shares of Eli Lilly worth $5.28M as of Q1 2026.
  • Texas Yale Capital Corp sold 276 Eli Lilly shares in Q1 2026, an estimated $280K.
  • Eli Lilly made up 0.15% of Texas Yale Capital Corp's portfolio in Q1 2026, its #97 holding.
  • Texas Yale Capital Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Texas Yale Capital Corp's Eli Lilly position peaked at $6.47M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.